Mufg Americas Holdings Corp Horizon Therapeutics Public LTD CO Transaction History

Mufg Americas Holdings Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	BUY	$58.92 - $84.67 $707 - $1,016	12 Added 2.64%	467 $29,000
Q3 2022 Oct 31, 2022	BUY	$58.92 - $84.67 $707 - $1,016	12 Added 2.64%	467 $29,000
Q1 2022 Dec 01, 2022	BUY	$86.42 - $109.81 $35,518 - $45,131	411 Added 934.09%	455 $48,000
Q1 2022 May 06, 2022	BUY	$86.42 - $109.81 $39,321 - $49,963	455 New	455 $48,000
Q3 2021 Nov 05, 2021	SELL	$91.91 - $110.37 $4,044 - $4,856	-44 Closed	0 $0
Q2 2021 Dec 01, 2022	SELL	$86.24 - $95.92 $36,479 - $40,574	-423 Reduced 90.58%	44 $4,000
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $3,794 - $4,220	44 New	44 $4,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.